Molecular characterisation of glutamate dehydrogenase gene defects in Japanese patients with congenital

H Fujioka1, Y Okano, H Inada

  • 1Department of Pediatrics, Osaka City University Graduate School of Medicine, Osaka, Japan.

Insights

Congenital hyperinsulinism and hyperammonaemia (CHH) results from glutamate dehydrogenase (GDH) gene mutations. Specific mutations L413V and G446D cause varying enzyme dysfunction, correlating with CHH patient phenotypes.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Congenital hyperinsulinism and hyperammonaemia (CHH) is a metabolic disorder linked to glutamate dehydrogenase (GDH) dysregulation.
  • GDH enzyme activity is modulated by GTP and ADP, crucial for regulating ammonia and glucose metabolism.

Purpose of the Study:

  • To characterize GDH gene mutations in two Japanese patients with CHH.
  • To correlate specific GDH mutations with biochemical and clinical phenotypes.

Main Methods:

  • Genetic analysis of the GDH gene in patients and their families.
  • Measurement of GDH enzyme activity and allosteric regulation in lymphoblasts.
  • COS cell expression studies to confirm pathogenicity of identified mutations.

Main Results:

  • Identified heterozygous, de novo GDH mutations L413V in patient 1 and G446D in patient 2.
  • Patient 1 (L413V) exhibited mild insensitivity to GTP inhibition and higher basal GDH activity, correlating with milder symptoms.
  • Patient 2 (G446D) showed severe GTP insensitivity, with mutations located in critical functional sites of the GDH enzyme.

Conclusions:

  • The identified GDH mutations L413V and G446D are disease-causing in CHH.
  • Mutation location and biochemical effects explain the varying clinical severity observed in the patients.
  • The antenna-like structure of GDH is critical for enzyme activity and is impacted by these mutations.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...